Palliative Care NL

Palliative Care Stockist Service – North Lincolnshire


NHS England on behalf of NL CCG

Service Period: 01/04/18 – 31/03/2021

The following extended hours pharmacies are to provide the North Lincolnshire palliative Care service:

  • Weldricks Pharmacy, The Ironstone Centre, West Street, Scunthorpe Part A & B Drugs
  • Boots Pharmacy, North Lincolnshire Shopping Park, Doncaster Road, Scunthorpe Part A Drugs
  • Ancora Pharmacy, 291 Ashby Road, Scunthorpe Part A Drugs
  • Riverside Pharmacy, Barnard Avenue, Brigg Part A Drugs
  • Unity Pharmacy, Cambridge Avenue Medical Centre, Cambridge Avenue, Bottesford, Scunthorpe Part A Drugs

North Lincolnshire Palliative Care Pharmacies and Drugs List

Please click the links below for information in relation to an updated specification for Palliative Care across North Lincolnshire.


Please Note: Due to ongoing shortages of Diamorphine amps, some prescribers will be switching to prescribe Morphine instead of Diamorphine; therefore changes have been made to the Drug lists.

A & B Drugs list

Palliative Care – Stock Check Part A

Palliative Care – Stock Check Part B


Read your Service Specification, sign the SLA and return to commissioner. Pharmacies will be accredited to provide the service via the PharmOutcomes platform once a signed SLA has been received by the commissioner.


Guide to claiming Part A and B sites PO instructions

Guide to claiming PART A sites PO instructions

All Claims to be made Quarterly on Pharmoutcomes. The quarters are as follows: 1st April to 30th June; 1st July to 30th September; 1st October to 31st December and 1st January to 31st March.

The pharmacy will enter the service delivery information onto the PharmOutcomes system and invoices will be generated automatically. Payments will be made by BACS within 28 days of the submitted invoice. Pharmacies can claim for their initial stock investment [Part A] or [Part A & Part B] as indicated in the SLA contract by completing a one-off ‘claim for date expired stock on PharmOutcomes. Also report OOS items via the same pharmoutcomes platform.